PDK1 regulates the progression of esophageal squamous cell carcinoma through metabolic reprogramming
Authors:
- 29 March 2023
- journal article
- research article
- Published by Wiley in Molecular Carcinogenesis
- Vol. 62 (6) , 866-881
Abstract
Esophageal squamous cell carcinoma (ESCC) is one of the deadliest human malignancies characterized by late‐stage diagnosis, drug resistance, and poor prognosis. Pyruvate dehydrogenase kinase 1 (PDK1) plays an important role in regulating the metabolic reprogramming of cancer cells. However, its expression, function, and regulatory mechanisms of PDK1 in ESCC have not been reported. In this study, we found that PDK1 silence and dichloroacetic acid (DCA) significantly inhibited the growth of ESCC cells and induced cell apoptosis. Interestingly, PDK1 is a direct target of miR‐6516‐5p, and miR‐6516‐5p/PDK1 axis suppressed the growth of ESCC cell by inhibiting glycolysis. Moreover, DCA and cisplatin (cis‐diammine‐dichloroplatinum, DDP) synergistically inhibited the progression and glycolysis ability of ESCC cells both in vitro and in vivo by increasing oxidative stress via the inhibition of the Keap1/Nrf2 signaling pathway. And, Tert‐butylhydroquinone (TBHQ), a specific activator of the Keap1/Nrf2 signaling, could diminish the synergic antitumor effects of DCA and DDP on ESCC cells. Collectively, our findings indicate that PDK1 may regulate the progression of ESCC by metabolic reprogramming, which provides new strategy for the treatment of ESCC.Keywords
This publication has 43 references indexed in Scilit:
- Protein S-glutathionylation alters superoxide/hydrogen peroxide emission from pyruvate dehydrogenase complexFree Radical Biology and Medicine, 2017
- Incidence trends in oesophageal cancer by histological type: An updated analysis in SwedenCancer Epidemiology, 2017
- Oncogenic role of PDK4 in human colon cancer cellsBritish Journal of Cancer, 2017
- Therapeutic applications of dichloroacetate and the role of glutathione transferase zeta-1Pharmacology & Therapeutics, 2017
- Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanismCellular and Molecular Life Sciences, 2016
- Overexpression of pyruvate dehydrogenase kinase supports dichloroacetate as a candidate for cutaneous melanoma therapyExpert Opinion on Therapeutic Targets, 2015
- Esophageal cancer: Risk factors, screening and endoscopic treatment in Western and Eastern countriesWorld Journal of Gastroenterology, 2015
- Overexpression of Pyruvate Dehydrogenase Kinase 3 Increases Drug Resistance and Early Recurrence in Colon CancerThe American Journal of Pathology, 2011
- Regulation of pyruvate dehydrogenase complex activity by reversible phosphorylationBiochemical Society Transactions, 2003
- Drug resistance and cancer chemotherapy strategy in breast cancerBreast Cancer Research and Treatment, 1983